Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study

Pain Research and Treatment

Volumn 2013, Issue , 2013, Pages

  Fitzcharles, Mary Ann ^a,b   Faregh, Neda ^b   Ste Marie, Peter A ^b,c   Shir, Yoram ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876573208     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2013/898493     Document Type: Article

References (28)

1. Wolfe F., Clauw D. J., Fitzcharles M. A., Goldenberg D. L., Katz R. S., Mease P., Russell A. S., Russell I. J., Winfield J. B., Yunus M. B., The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 2010 62 5 600 610 2-s2.0-77951735184 10.1002/acr.20140
2. Bennett R. M., Jones J., Turk D. C., Russell I. J., Matallana L., An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders 2007 8, article 27 2-s2.0-33947366834 10.1186/1471-2474-8-27 (Pubitemid 46449873)
3. Fitzcharles M.-A., Ste-Marie P. A., Gamsa A., Ware M. A., Shir Y., Opioid use, misuse, and abuse in patients labeled as fibromyalgia. The American Journal of Medicine 2011 124 10 955 960 10.1016/j.amjmed.2011.05.031
4. Goldenberg D. L., Ryan K., Chandran A., Zlateva G., What is the true cost of fibromyalgia to our society: results from a cross-sectional survey in the United States. Arthritis and Rheumatism 2009 60 supplement 10 104
5. Okie S., A flood of opioids, a rising tide of deaths. The New England Journal of Medicine 2010 363 21 1981 1985 2-s2.0-78549264128 10.1056/NEJMp1011512
6. Melzack R., The McGill pain questionnaire: major properties and scoring methods. PAIN 1975 1 3 277 299 2-s2.0-0016725211 10.1016/0304-3959(75)90044-5
7. Burckhardt C. S., Clark S. R., Bennett R. M., The fibromyalgia impact questionnaire: development and validation. Journal of Rheumatology 1991 18 5 728 733 2-s2.0-0026165648
8. Fries J. F., Spitz P., Kraines R. G., Holman H. R., Measurement of patient outcome in arthritis. Arthritis and Rheumatism 1980 23 2 137 145 2-s2.0-0018882143 (Pubitemid 10164318)
9. Meenan R. F., Gertman P. M., Mason J. H., Measuring health status in arthritis: the arthritis impact measurement scales. Arthritis and Rheumatism 1980 23 2 146 152 2-s2.0-0018837205 (Pubitemid 10164319)
10. Sullivan M. J. L., Bishop S. R., Pivik J., The pain catastrophizing scale: development and validation. Psychological Assessment 1995 7 4 524 532 2-s2.0-0029584617 10.1037/1040-3590.7.4.524 (Pubitemid 26017352)
11. Boomershine C. S., Crofford L. J., A symptom-based approach to pharmacologic management of fibromyalgia. Nature reviews Rheumatology 2009 5 4 191 199 2-s2.0-67650486524 10.1038/nrrheum.2009.25
12. Abeles A. M., Pillinger M. H., Solitar B. M., Abeles M., Narrative review: the pathophysiology of fibromyalgia. Annals of Internal Medicine 2007 146 10 726 734 2-s2.0-34250213699 (Pubitemid 351640000)
13. Younger J. W., Zautra A. J., Cummins E. T., Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS ONE 2009 4 4 2-s2.0-65249104842 10.1371/journal.pone. 0005180 e5180
14. Choy E. H., Mease P. J., Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheumatic Disease Clinics of North America 2009 35 2 329 337 2-s2.0-67651238729 10.1016/j.rdc.2009.05.002
15. Boulanger A., Clark A. J., Squire P., Cui E., Horbay G. L. A., Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Research and Management 2007 12 1 39 47 2-s2.0-34248525264 (Pubitemid 46744776)
16. Furlan A. D., Sandoval J. A., Mailis-Gagnon A., Tunks E., Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ: Canadian Medical Association Journal 2006 174 11 1589 1594 2-s2.0-33646851193 10.1503/cmaj.051528 (Pubitemid 43829515)
17. Bennett R. M., Kamin M., Karim R., Rosenthal N., Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. The American Journal of Medicine 2003 114 7 537 545 2-s2.0-0037716856 10.1016/S0002-9343(03)00116-5 (Pubitemid 36577256)
18. Biasi G., Manca S., Manganelli S., Marcolongo R., Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. International Journal of Clinical Pharmacology Research 1998 18 1 13 19 2-s2.0-0031693130 (Pubitemid 28472883)
19. Häuser W., Thieme K., Turk D. C., Guidelines on the management of fibromyalgia syndrome: a systematic review. European Journal of Pain 2010 14 1 5 10 2-s2.0-72049123263 10.1016/j.ejpain.2009.01.006
20. Carville S. F., Arendt-Nielsen S., Bliddal H., Blotman F., Branco J. C., Buskila D., Da Silva J. A. P., Danneskiold-Samsøe B., Dincer F., Henriksson C., Henriksson K. G., Kosek E., Longley K., McCarthy G. M., Perrot S., Puszczewicz M., Sarzi-Puttini P., Silman A., Späth M., Choy E. H., EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases 2008 67 4 536 541 2-s2.0-41849093775 10.1136/ard.2007.071522 (Pubitemid 351498437)
21. Burckhardt C., Goldenberg D., Crofford L., Gerwin R., Gowans S., Kackson, Guideline for the management of fibromyalgia syndrome. Pain in Adults and Children. APS Clinical Practice Guideline Series 2005 4 Glenview, Ill, USA American Pain Society
22. Kurita G. P., Sjøgren P., Juel K., Højsted J. H., Ekholm O., The burden of chronic: a cross-sectional survey focussing on diseases, immigration, and opioid use. Pain 2012 153 12 2332 2338 10.1016/j.pain. 2012.07.023
23. Lee M., Silverman S., Hansen H., Patel V., Manchikanti L., A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011 14 2 145 161 2-s2.0-79952841662
24. Chou R., Fanciullo G. J., Fine P. G., Adler J. A., Ballantyne J. C., Davies P., Donovan M. I., Fishbain D. A., Foley K. M., Fudin J., Gilson A. M., Kelter A., Mauskop A., O'Connor P. G., Passik S. D., Pasternak G. W., Portenoy R. K., Rich B. A., Roberts R. G., Todd K. H., Miaskowski C., Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain 2009 10 2 113.e22 130.e22 10.1016/j.jpain.2008.10.008
25. Crofford L. J., Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nature Reviews Rheumatology 2010 6 4 191 197 2-s2.0-77950604262 10.1038/nrrheum.2010.24
26. Hartung D. M., Middleton L., Haxby D. G., Koder M., Ketchum K. L., Chou R., Rates of adverse events of long-acting opioids in a state medicaid program. Annals of Pharmacotherapy 2007 41 6 921 928 2-s2.0-34250165387 10.1345/aph.1K066 (Pubitemid 46917617)
27. Manchikanti L., Fellows B., Ailinani H., Pampati V., Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010 13 5 401 435 2-s2.0-77957999987
28. Furlan A. D., Reardon R., Weppler C., Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ: Canadian Medical Association Journal 2010 182 9 923 930 2-s2.0-77953595312 10.1503/cmaj.100187